Patient Pathfinder: Clinical Trials
Clinical Trials for Bladder Cancer
Every life-saving or life-extending treatment that’s available today for cancer started its journey in a clinical trial. A clinical trial is a study that helps doctors better understand cancer, and discover safer and more effective ways to treat it.
Clinical trials also give patients a chance to try a treatment before it’s approved by the U.S. Food and Drug Administration.
There are 277 active Bladder Cancer trials
Study of Genistein in Reducing Side Effects of Superficial Bladder Cancer Treatment
Study Type: Interventional Phase 2
Study of 2141-V11 in People With Non-muscle Invasive Bladder Cancer That Did Not Respond to Standard Treatment
Study Type: Interventional Phase 1
Radiation Therapy and Durvalumab With or Without Tremelimumab in Treating Participants With Unresectable, Locally Advanced, or Metastatic Bladder Cancer
Study Type: Interventional Phase 2
Risk Enabled Therapy After Initiating Neoadjuvant Chemotherapy for Bladder Cancer (RETAIN)
Study Type: Interventional Phase 2
A Study of Several Radiation Doses for Patients With Progression on Immunotherapy/Checkpoint Inhibitors
Study Type: Interventional Phase 2
LaserEn: SOLTIVEâ„¢ Thulium Laser Fiber En Bloc Resection of Bladder Tumors
Study Type: Observational
Decision Making for Urinary Diversion in Patients With Bladder Cancer
Study Type: Observational
Atezolizumab + Guadecitabine in Patients With Checkpoint Inhibitor Refractory or Resistant Urothelial Carcinoma
Study Type: Interventional Phase 2
There are 277 active Bladder Cancer trials
Filter Results
Phase
Study Type
Need more help finding a clinical trial that's the right fit?
Explore our Clinical Trial Finder.
Start NowNeed more help finding a clinical trial that's the right fit?
Explore our Clinical Trial Finder.
Start Now